Randomized trial · people

Larazotide: 0.5 mg arm eased celiac symptoms on gluten-free diet

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In one mid-stage trial, only the lowest larazotide dose eased celiac symptoms beyond a gluten-free diet alone, and the higher doses showed no benefit.

Kind
Randomized trial
Studied in
People
Number studied
342
Published
2015
Journal
Gastroenterology

What they tested

The team tested whether larazotide acetate could ease ongoing celiac disease symptoms in adults who still had them while staying on a gluten-free diet.

How the study was done

A multicenter, randomized, double-blind, placebo-controlled phase II trial in 342 adults with celiac disease who had kept a gluten-free diet for 12 months or longer. They took 0.5, 1, or 2 mg 3 times daily or placebo (a dummy treatment) for 12 weeks, with 4 weeks on placebo before and 4 weeks on placebo after.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking larazotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

The 0.5 mg arm met the main goal, with fewer gut symptoms than placebo on the Celiac Disease Gastrointestinal Symptom Rating Scale. On exploratory measures, the 0.5 mg arm had 26% fewer symptomatic days, 31% more improved symptom days, more people with abdominal pain cut by 50% or more for 6 or more of the 12 weeks, and less headache and tiredness. The 1 mg and 2 mg arms did no better than placebo on any measure. Safety was similar to placebo.

What it doesn’t show

This was a 12-week phase II trial, and only the lowest dose beat placebo while the higher doses did not, so the results were mixed. Most of the extra benefits came from exploratory measures, not the main goal.

The paper

Leffler et al. Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. Gastroenterology. 2015.

The compound

More studies on Larazotide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking larazotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo